These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


151 related items for PubMed ID: 8568546

  • 1. In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin.
    Novelli A, Mazzei T, Fallani S, Cassetta MI, Conti S.
    J Chemother; 1995 Aug; 7(4):355-62. PubMed ID: 8568546
    [Abstract] [Full Text] [Related]

  • 2. Postantibiotic effect of aminoglycosides on staphylococci.
    Isaksson B, Maller R, Nilsson LE, Nilsson M.
    J Antimicrob Chemother; 1993 Aug; 32(2):215-22. PubMed ID: 8226423
    [Abstract] [Full Text] [Related]

  • 3. Synergism and postantibiotic effect of tobramycin and Melaleuca alternifolia (tea tree) oil against Staphylococcus aureus and Escherichia coli.
    D'Arrigo M, Ginestra G, Mandalari G, Furneri PM, Bisignano G.
    Phytomedicine; 2010 Apr; 17(5):317-22. PubMed ID: 19699074
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
    Melby K, Midtvedt T, Dahl O.
    Chemotherapy; 1979 Apr; 25(5):286-95. PubMed ID: 113179
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
    Watanakunakorn C, Tisone JC.
    Antimicrob Agents Chemother; 1982 Nov; 22(5):903-5. PubMed ID: 6924825
    [Abstract] [Full Text] [Related]

  • 8. Duration and clinical relevance of postantibiotic effect in relation to the dosing interval.
    den Hollander JG, Fuursted K, Verbrugh HA, Mouton JW.
    Antimicrob Agents Chemother; 1998 Apr; 42(4):749-54. PubMed ID: 9559777
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)].
    Campello C, Crevatin E.
    Ann Sclavo; 1977 Apr; 19(3):437-45. PubMed ID: 415672
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of tobramycin on characteristics of strains of Acinetobacter species].
    Hostacká A.
    Ceska Slov Farm; 2003 Jul; 52(4):193-7. PubMed ID: 12924072
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M, Brun Y, Forey F, Fleurette J.
    Nouv Presse Med; 1982 Nov 18; 11(46):3391-5. PubMed ID: 7155846
    [Abstract] [Full Text] [Related]

  • 17. Different patterns of bacterial DNA synthesis during postantibiotic effect.
    Gottfredsson M, Erlendsdóttir H, Gudmundsson A, Gudmundsson S.
    Antimicrob Agents Chemother; 1995 Jun 18; 39(6):1314-9. PubMed ID: 7574522
    [Abstract] [Full Text] [Related]

  • 18. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
    Hybenová D, Majtán V.
    Pharmazie; 1997 Feb 18; 52(2):157-9. PubMed ID: 9122276
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.